National Pain Organizations Converge at PAINWee...(nd pain is the management company for PA...),Health
Navigation Links
National Pain Organizations Converge at PAINWeek(TM) 2008
Date:3/26/2008
nd pain, is the management company for PAINWeek.
'/>"/>
| SOURCE Aventine HealthSciences Copyright©2008 PR Newswire. All rights reserved |
Related medicine news :
1. China Yingxia International Announces 2007 Fourth Quarter and Full Year Financial Results Conference Call
2. Murad Expands International Presence With Appointment of Danny Guez
3. National Health Education Tour to Kick-Off in Atlanta
4. International Eye Foundation Announces Partnership with Newport Creative Communications
5. China RuiTai International Holdings Retains CCG Elite for Investor Relations Services
6. Coalition to Prevent Deep-Vein Thrombosis (DVT) Turns Awareness Into Action as it Declares First-Of-Its-Kind National DVT Screening Day
7. Jopari Ramps Up Texas eBill Production With National and Regional Carriers and Medical Billing Technology Suppliers
8. Cantel Medical Corp. and National Safety Council Launch Joint Initiative to Prepare Businesses and Individuals for Flu Pandemic
9. PAREXEL International to Present at Bank of America 2008 Smid Cap Conference
10. Childrens Hospitals and Clinics of Minnesota COO, Julie Morath, Appointed to National Quality Forum Committee
11. Stella Mora Henry to Present The Eldercare Handbook at Aging in America Joint Conference of National Council on Aging & The American Society on Aging March 27-29
Post Your Comments:
Breaking Medicine News(10 mins):Health News:www.RightMedicare.com Launches to Offer Non-Biased Medicare Enrollment Assistance 2Health News:Dr. Daniel Von Hoff named honoree of Scottsdale Healthcare Foundation Honor Ball 2Health News:Dr. Daniel Von Hoff named honoree of Scottsdale Healthcare Foundation Honor Ball 3Health News:Concord Grape Juice Shown to Help Keep Hearts and Minds Healthy 2Health News:Concord Grape Juice Shown to Help Keep Hearts and Minds Healthy 3Health News:Concord Grape Juice Shown to Help Keep Hearts and Minds Healthy 4Health News:The Kenneth Rainin Foundation Awards $457,000 in Grants to Support Dance, Theater, Film and Early Literacy in the San Francisco Bay Area 2Health News:The Kenneth Rainin Foundation Awards $457,000 in Grants to Support Dance, Theater, Film and Early Literacy in the San Francisco Bay Area 3Health News:Blue Care Network CEO Jeanne Carlson to Retire at the End of February 2010 2
[0] www.RightMedicare.com Launches to Offer Non-Biased Medicare Enrollment Assistance[1] Dr. Daniel Von Hoff named honoree of Scottsdale Healthcare Foundation Honor Ball[1] Concord Grape Juice Shown to Help Keep Hearts and Minds Healthy[0] The Kenneth Rainin Foundation Awards $457,000 in Grants to Support Dance, Theater, Film and Early Literacy in the San Francisco Bay Area[0] Blue Care Network CEO Jeanne Carlson to Retire at the End of February 2010
Other Medicine News:Health News:Lack of health surveillance system puts Canada at risk 2Health News:Siemens Showcases Innovative Leadership in Molecular Imaging at SNM 2008 2Health News:Siemens Showcases Innovative Leadership in Molecular Imaging at SNM 2008 3Health News:Siemens Showcases Innovative Leadership in Molecular Imaging at SNM 2008 4Health News:AVP Crocs Tour Announces Season-Long Contract With Naked Juice 2Health News:AVP Crocs Tour Announces Season-Long Contract With Naked Juice 3Health News:MassMutual Announces Web Site Enhancement That Helps Employees Save for Retirement Sooner 2Health News:Adalimumab therapy effective in AS, RA and PsA patients refractory to other anti-TNF therapies 2Health News:Parental Insomnia Can Harm Adolescent Children 2Health News:Parental Insomnia Can Harm Adolescent Children 3
Lack of health surveillance system puts Canada at riskSiemens Showcases Innovative Leadership in Molecular Imaging at SNM 2008AVP Crocs Tour Announces Season-Long Contract With Naked JuiceMassMutual Announces Web Site Enhancement That Helps Employees Save for Retirement SoonerAdalimumab therapy effective in AS, RA and PsA patients refractory to other anti-TNF therapiesParental Insomnia Can Harm Adolescent Children
Breaking Medicine Technology:Anesiva Completes Sale of its Zingo(TM) Assets to Powder Pharmaceuticals and Lee's Pharmaceuticals 2Al Novak Elected Chairman of the Board of OrbusNeich Medical 2National Ergonomics Expo Sees Immediate 93% Exhibit Space Renewal for 2010; Equipois, Herman Miller, Neutral Posture, REDpoint International Win 2009 Attendees' Choice New Product Awards 2Beckman Coulter Declares Quarterly Dividend Payout of 240 17 Per Share 13218 1VIDEO from Medialink and the American Academy of Orthopaedic Surgeons 3A American Joint Replacement Registry Announced 52848 1VIDEO from Medialink and the American Academy of Orthopaedic Surgeons 3A American Joint Replacement Registry Announced 52848 2Tight Management of Type 1 Diabetes Worth the Effort 52844 1Tight Management of Type 1 Diabetes Worth the Effort 52844 2Tight Management of Type 1 Diabetes Worth the Effort 52844 3
[0] Anesiva Completes Sale of its Zingo(TM) Assets to Powder Pharmaceuticals and Lee's Pharmaceuticals[0] Al Novak Elected Chairman of the Board of OrbusNeich Medical[0] National Ergonomics Expo Sees Immediate 93% Exhibit Space Renewal for 2010; Equipois, Herman Miller, Neutral Posture, REDpoint International Win 2009 Attendees' Choice New Product Awards
Other Medicine Technology:Human Genome Sciences Reports Positive Late-Breaker Results at EASL from ACHIEVE Phase 3 Trials of Albuferon(R) in Patients with Chronic Hepatitis C 2Human Genome Sciences Reports Positive Late-Breaker Results at EASL from ACHIEVE Phase 3 Trials of Albuferon(R) in Patients with Chronic Hepatitis C 3Human Genome Sciences Reports Positive Late-Breaker Results at EASL from ACHIEVE Phase 3 Trials of Albuferon(R) in Patients with Chronic Hepatitis C 4Human Genome Sciences Reports Positive Late-Breaker Results at EASL from ACHIEVE Phase 3 Trials of Albuferon(R) in Patients with Chronic Hepatitis C 5Human Genome Sciences Reports Positive Late-Breaker Results at EASL from ACHIEVE Phase 3 Trials of Albuferon(R) in Patients with Chronic Hepatitis C 6Human Genome Sciences Reports Positive Late-Breaker Results at EASL from ACHIEVE Phase 3 Trials of Albuferon(R) in Patients with Chronic Hepatitis C 7Human Genome Sciences Reports Positive Late-Breaker Results at EASL from ACHIEVE Phase 3 Trials of Albuferon(R) in Patients with Chronic Hepatitis C 8Intarcia Therapeutics, Inc. Announces Completion of Enrollment of ITCA 650 Phase 1b Study for the Treatment of Type 2 Diabetes 2Intarcia Therapeutics, Inc. Announces Completion of Enrollment of ITCA 650 Phase 1b Study for the Treatment of Type 2 Diabetes 3
| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |